Markets Today LIVE: Indian benchmark equity indices BSE Sensex and Nifty50 were trading higher on Monday, amid positive global cues
Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025
Vedanta's consolidated Ebitda is expected to increase to more than Rs 44,000-45,000 cr by the end of FY25 (Rs 36,455 cr in FY24), supported by favourable prices and cost reduction
Vodafone Idea stock is expected to trade with a favourable bias in the near-term as long as the stock holds above Rs 9.50 - Rs 9.35 support zone, suggests the technical charts.